Cardiology (all articles)
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies.
13 Jan, 2022 | 08:32h | UTC
The year in cardiovascular medicine 2021: dyslipidemia.
13 Jan, 2022 | 08:30h | UTCThe year in cardiovascular medicine 2021: dyslipidemia – European Heart Journal
The year in cardiovascular medicine 2021: digital health and innovation.
13 Jan, 2022 | 08:27h | UTCThe year in cardiovascular medicine 2021: digital health and innovation – European Heart Journal
Systematic Review: In patients who are about to undergo noncardiac surgery, biomarkers (BNP/NT‐proBNP, troponin or their combination) may provide added prognostic value to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all‐cause mortality. The results cannot be interpreted as conclusive due to the high risks of bias in most papers.
13 Jan, 2022 | 08:15h | UTC
Statement on potential drug-drug interactions between Ritonavir-boosted Nirmatrelvir (Paxlovid) and concomitant medications; antiarrhythmics, oral anticoagulants, immunosuppressants, anticonvulsants, antineoplastics, and neuropsychiatric drugs are among the drugs of concern.
12 Jan, 2022 | 09:09h | UTCCommentaries:
Pfizer antiviral pills may be risky with other medications – NBC News
See also: What’s New in the Guidelines – NIH COVID-19 Treatment Guidelines
Clinical Review: Diagnostic reasoning in cardiovascular medicine.
12 Jan, 2022 | 08:49h | UTCDiagnostic reasoning in cardiovascular medicine – The BMJ
RCT: Among patients younger than 21 years of age with provoked thromboembolism, anticoagulation for 6 weeks was non-inferior vs. 12 weeks on the risk of recurrence and bleeding events.
12 Jan, 2022 | 08:53h | UTCEffect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Duration of Anticoagulant Treatment for Acute Provoked Venous Thromboembolism in Pediatric Patients – JAMA (free for a limited period)
Cohort Study: Higher consumption of olive oil linked to lower risk of cardiovascular, cancer, and all-cause mortality.
12 Jan, 2022 | 08:41h | UTCConsumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries:
Higher olive oil intake associated with lower risk of CVD mortality – American College of Cardiology
AHA Scientific Statement: Comprehensive management of cardiovascular risk factors for adults with Type 2 Diabetes.
11 Jan, 2022 | 02:40h | UTC
In 1st, US surgeons transplant pig heart into human patient.
11 Jan, 2022 | 02:34h | UTCIn 1st, US surgeons transplant pig heart into human patient – Associated Press
Review: New aspects in the management of hypertension in patients with chronic kidney disease not on renal replacement therapy.
11 Jan, 2022 | 02:22h | UTC
The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
11 Jan, 2022 | 02:20h | UTCRelated:
NICE Guideline | Acute heart failure: diagnosis and management.
The ‘ten commandments’ for the 2021 ESC Guidelines on CVD prevention.
Registry Study: Determinants of outcomes following surgery for type A acute aortic dissection.
11 Jan, 2022 | 02:12h | UTC
Commentary on Twitter
Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit https://t.co/nKH9jJLjdp #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/5C5jGd4DV6
— European Society of Cardiology Journals (@ESC_Journals) September 30, 2021
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
9 Jan, 2022 | 01:05h | UTCRisk of myocarditis following sequential COVID-19 vaccinations by age and sex – medRxiv
Note: this study is an updated analysis of a recent study published in Nature Medicine; see below:
AHA Scientific Statement | Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy.
8 Jan, 2022 | 23:16h | UTCNews Release: High blood pressure treatment in pregnancy is safe, prevents maternal heart risks – American Heart Association
Commentary on Twitter
Have you had a chance to check out the new Scientific Statement From the American Heart Association?!?
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Associationhttps://t.co/hs6zPwOP2N pic.twitter.com/CUs1jxCP5M
— Hypertension (@HyperAHA) December 20, 2021
AHA names top heart disease and stroke research advances of 2021.
8 Jan, 2022 | 23:14h | UTCAHA names top heart disease and stroke research advances of 2021 – American Heart Association
In a large retrospective cohort study of patients with atrial fibrillation 65 years or older, treatment with rivaroxaban compared with apixaban was associated with increased risk of major ischemic or hemorrhagic events.
8 Jan, 2022 | 22:37h | UTCCommentary: Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study – TCTMD
Related:
Retrospective cohort study: In patients with venous thromboembolism (VTE), treatment with apixaban was associated with lower rates for recurrent VTE and bleeding compared to rivaroxaban.
8 Jan, 2022 | 22:36h | UTCCommentaries:
Apixaban shows superior effectiveness, safety compared to rivaroxaban – ACP Internist
Recurrent VTE and Bleeding With Apixaban vs. Rivaroxaban – American College of Cardiology
NICE Guideline | Acute heart failure: diagnosis and management.
17 Dec, 2021 | 08:48h | UTCAcute heart failure: diagnosis and management – National Institute for Health and Care Excellence
Guideline: Prevention, diagnosis, and management of post-surgical mediastinitis in adults.
17 Dec, 2021 | 08:41h | UTC
Perspective: Introducing nephrocardiology.
16 Dec, 2021 | 08:31h | UTCIntroducing Nephrocardiology – Clinical Journal of the American Society of Nephrology
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.
15 Dec, 2021 | 08:43h | UTCNews release: COVID-19 infection, more likely than vaccines, to cause rare cardiovascular complications – University of Oxford
Commentaries on Twitter
Hugely important work from @JuliaHCox and colleagues:
In people <40, Pfizer carries a much lower risk of myocarditis than either Moderna **or SARS-CoV-2 infection** (annotations added)https://t.co/wqRts3ALqy pic.twitter.com/fnn1T39h1b
— David Juurlink (@DavidJuurlink) December 14, 2021
A case series published in @NatureMedicine shows an increased risk of myocarditis after receiving the Astra-Zeneca-Oxford, Pfizer-BioNTech and the Moderna COVID-19 vaccines, but SARS-CoV-2 infection carried a greater risk of myocarditis. https://t.co/6y7pZlJN70 pic.twitter.com/cBlKz9sUkg
— Nature Portfolio (@NaturePortfolio) December 14, 2021
Just published @NatureMedicine
The most comprehensive assessment of the rare events of myocarditis, pericarditis, arrhythmias after COVID and AZ, mRNA vaccineshttps://t.co/0bEdMJSLXg pic.twitter.com/eC5JOx0CmG— Eric Topol (@EricTopol) December 14, 2021
Randomized crossover trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy.
15 Dec, 2021 | 08:23h | UTCRandomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Early hospital discharge feasible following PCI for patients with STEMI.
15 Dec, 2021 | 08:24h | UTCEarly Hospital Discharge Following PCI for Patients With STEMI – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Consensus Recommendations: Non-invasive imaging in coronary syndromes.
14 Dec, 2021 | 08:51h | UTC